Pablo Gargallo

Valencia, VC, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 19 publications

Novel intragenic deletion within the FXN gene in a patient with typical phenotype of Friedreich ataxia: may be more prevalent than we think?

Novel intragenic deletion within the FXN gene in a patient with typical phenotype of Friedreich ataxia: may be more prevalent than we think?

Journal: BMC medical genomics

Published: December 05, 2022

Personalized Medicine in Infant Population with Cancer: Pharmacogenetic Pilot Study of Polymorphisms Related to Toxicity and Response to Chemotherapy.

Personalized Medicine in Infant Population with Cancer: Pharmacogenetic Pilot Study of Polymorphisms Related to Toxicity and Response to Chemotherapy.

Journal: Cancers

Published: November 24, 2022

Next-Generation DNA Sequencing-Based Gene Panel for Diagnosis and Genetic Risk Stratification in Onco-Hematology.

Next-Generation DNA Sequencing-Based Gene Panel for Diagnosis and Genetic Risk Stratification in Onco-Hematology.

Journal: Cancers

Published: January 04, 2022

Genomic characterization and tumor evolution in paired samples of metaplastic breast carcinoma.

Genomic characterization and tumor evolution in paired samples of metaplastic breast carcinoma.

Journal: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc

Published: October 28, 2021

Germline Predisposition to Pediatric Cancer, from Next Generation Sequencing to Medical Care.

Germline Predisposition to Pediatric Cancer, from Next Generation Sequencing to Medical Care.

Journal: Cancers

Published: September 15, 2021

Germline variant in Ctcf links mental retardation to Wilms tumor predisposition.

Germline variant in Ctcf links mental retardation to Wilms tumor predisposition.

Journal: European journal of human genetics : EJHG

Published: September 14, 2021

Pharmacogenetics in Neuroblastoma: What Can Already Be Clinically Implemented and What Is Coming Next?

Pharmacogenetics in Neuroblastoma: What Can Already Be Clinically Implemented and What Is Coming Next?

Journal: International journal of molecular sciences

Published: August 17, 2021

Comprehensive NGS Panel Validation for the Identification of Actionable Alterations in Adult Solid Tumors.

Comprehensive NGS Panel Validation for the Identification of Actionable Alterations in Adult Solid Tumors.

Journal: Journal of personalized medicine

Published: March 24, 2021

Next-Generation Sequencing Identifies Potential Actionable Targets in Paediatric Sarcomas.

Next-Generation Sequencing Identifies Potential Actionable Targets in Paediatric Sarcomas.

Journal: Journal of personalized medicine

Published: February 19, 2021

Retinoblastoma and mosaic 13q deletion: a case report.

Retinoblastoma and mosaic 13q deletion: a case report.

Journal: International journal of retina and vitreous

Published: January 25, 2021

MTHFR and VDR Polymorphisms Improve the Prognostic Value of MYCN Status on Overall Survival in Neuroblastoma Patients.

MTHFR and VDR Polymorphisms Improve the Prognostic Value of MYCN Status on Overall Survival in Neuroblastoma Patients.

Journal: International journal of molecular sciences

Published: February 26, 2020

Publisher Correction: Clinical Features of Neuroblastoma With 11q Deletion: An Increase in Relapse Probabilities In Localized And 4S Stages.

Publisher Correction: Clinical Features of Neuroblastoma With 11q Deletion: An Increase in Relapse Probabilities In Localized And 4S Stages.

Journal: Scientific reports

Published: February 02, 2020

Showing 1-12 of 19

Last Updated: 09/26/2026